Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 Industry Snapshot
    • 2022 MA Life Sciences Workforce Analysis Report
    • 2021 State of Diversity, Equity, & Inclusion Report
    • Economic Development
    • Value of Health
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Bioversity at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Momenta Pharmaceuticals, Inc.

Life Sciences | Drug Development
Cambridge, MA 617-491-9700 Website

Overview

Momenta Pharmaceuticals, Inc. is a leader in applying breakthroughs in understanding the chemistry and biology of complex sugars to the discovery, development, and commercialization of drug products. In its short history, Momenta has built a diversified pipeline of product candidates comprised of novel therapeutics and the application of its technology to existing products and molecules. Complex sugars play a fundamental role in most basic cellular functions in addition to serving as modulators of the activity of critical proteins. While scientists have long recognized that sugars are important, efforts to decipher the specific roles that sugars play in promoting or treating human diseases have been impeded by the lack of technology capable of deciphering the incredible information density contained in sugar molecules. Momenta’s proprietary technology provides a more complete understanding of disease and drug action by enabling, for the first time, high throughput sequencing, precise chemical structure characterization, and engineering of complex sugars and glycosylated biomolecules. Momenta leverages this insight to develop novel therapeutics, make improvements to existing drugs, and discover new biological processes and pathways. Momenta’s areas of focus include cardiovascular disease, oncology, glycoprotein analysis and engineering, and non-invasive drug delivery. Founded in 2001, Momenta is headquartered in Cambridge, MA.

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2023 All Rights Reserved